Changeflow GovPing Healthcare Multimodal Soft Tissue Imaging for Dermal Lesions
Routine Notice Added Final

Multimodal Soft Tissue Imaging for Dermal Lesions

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO granted patent US12599299B2 to Dentsply Sirona Inc. on April 14, 2026. The patent covers a method and device for multimodal imaging of dermal and mucosal lesions using at least two imaging modalities, including 3D scanning, with information on distance and angulation between the scanning device and the tissue. The patent contains 28 claims.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO granted patent US12599299B2 to Dentsply Sirona Inc. for a method and device enabling multimodal imaging of dermal and mucosal lesions. The technology combines at least two imaging modalities including a 3D scan of the lesion, while capturing distance and angulation data between the scanning device and the dermis or mucosa, and maps the additional modality over the 3D data.

For affected parties in medical device manufacturing and clinical diagnostics, this patent establishes intellectual property rights that may restrict development of similar multimodal soft tissue imaging technologies. Competitors developing 3D dermal scanning devices should review the patent claims to assess potential licensing needs or design-around options.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Method and apparatus for multimodal soft tissue diagnostics

Grant US12599299B2 Kind: B2 Apr 14, 2026

Assignee

Dentsply Sirona Inc.

Inventors

Thomas Ertl

Abstract

A method and device for multimodal imaging of dermal and mucosal lesions. The method includes using at least two imaging modalities from which one is a 3D scan of the lesion, and, additionally providing information on the distance and angulation between scanning device and the dermis or mucosa and mapping at least the second modality over the 3D data.

CPC Classifications

A61B 1/24 A61B 5/0035 A61B 5/0088

Filing Date

2021-05-20

Application No.

17927054

Claims

28

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12599299B2

Who this affects

Applies to
Medical device makers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical imaging device manufacturing Diagnostic device development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!